Preschoolers and Asymptomatic COVID-19 Cases: More Likely Than in Other Ages?

Findings reported in JAMA Network Open today show more than a one-third of infected preschoolers are asymptomatic. The results call into question COVID-19 prevention strategies based on screening young children for symptoms.

Preschool-aged children infected with the SARS-CoV-2 virus are frequently asymptomatic and their symptoms are not correlated with viral load, according to the results of a study published today in JAMA Network Open. The results suggest that efforts to control COVID-19 transmission by screening young children for symptoms may be misguided.

An editorial accompanying the study says increasing the number of young children who are vaccinated against COVID-19 is likely the best strategy for reducing transmission in preschool children. In June, the FDA granted an emergency use authorization for the Pfizer and Moderna vaccines in preschool children and CDC’s Advisory Committee on Immunization Practices issued interim recommendation for their use in small children.

Ruth A. Karron, M.D., a professor at Johns Hopkins and an infectious disease researcher, and her colleagues reported results that show that a little over one-third (36.8%) of children, ages 0-4, infected with the SARS-CoV-2 in their study were asymptomatic compared. In contrast, about 1 in 7 (14.3%) of the infected adults in the study were asymptomatic. Karron and her colleagues also found that the number of symptoms was not correlated to viral load among children whereas among but symptoms and viral were correlated among adults.

The study was conducted between Nov. 24, 2020, and Oct. 15, 2021. The omicron variants started circulating in the U.S. in November 2021, so after the eight-month study was completed.

One of the strengths of the study was that it was designed prospectively. The researchers enrolled 175 Maryland households. The households comprised 256 children, ages 0 to 4; 100 children, ages 5 to 17, and 334 adults. The participating households filled out weekly questionnaires about possible COVID-19 symptoms and submitted nasal swabs for polymerase chain reaction (PCR) testing that is more reliable that the at-home rapid antigen tests. They also collected blood samples at the beginning, end and mid-way through the study.

Fifty-four (7.8%) of the 690 people in the study experienced SARS-CoV-2 infections.

One of the limitations of the study is that the numbers of infected participants was quite small, especially when they were broken down by age group. For example, the finding that infected young children are more commonly asymptomatic was based a comparison between seven of the 19 infected children in the 0-4 age group to the adult group of 21 infected individuals, three of whom were asymptomatic.

The study also suffered from lack of diversity: 87.4% of the study participants self-reported their race as White.

This article originally appeared on Managed Healthcare Executive.